结直肠癌中的后生物:干预机制和前景
Wei Xie1, Yu-Sen Zhong1, Xue-Jian Li1
1Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China.
Frontiers in microbiology
|March 7, 2024
概括
后生物质,有益的微生物成分和代谢物,通过调节肠道微生物群,显示出对抗结直肠癌 (CRC) 的前途. 这些比益生菌更安全的替代品为CRC预防和治疗提供了新的途径.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 结肠直肠癌 (CRC) 是一个全球性的健康问题,受到饮食,环境和遗传学的影响.
- 肠道微生物群失生症通过产生有毒代谢物,导致炎症和DNA损伤,为CRC做出贡献.
- 从有益的微生物中衍生出的后生物,提供了一种稳定和安全的方法来调节肠道健康.
研究的目的:
- 审查肠道微生物群在CRC发展中的作用.
- 为了探索后生物的抗瘤机制.
- 讨论后生物在CRC诊断和治疗中的潜力.
主要方法:
- 对肠道微生物群和CRC研究的文献综述.
- 分析后生物成分及其抗癌活性.
- 讨论关于用于CRC管理的后生物质的当前研究.
主要成果:
- 肠道微生物群的变化与CRC病原发生有关.
- 后生物体通过各种机制表现出抗瘤作用.
- 后生物质在稳定性和安全性方面比益生菌具有优势.
结论:
- 后生物药物是预防和治疗CRC的一个有希望的策略.
- 需要进一步的研究,以充分阐明后生物在CRC中的潜力和局限性.
- 用后生物制剂调节肠道微生态可能为结直肠癌提供新的治疗方法.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs for Treatment of Constipation-Predominant IBS
163
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
163


